Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Rainer M. ErdtmannSEE REMARKS | Open-market buy | 25/12/11 | 25/12/15 | 30,000 sh | $1.43 | $42,900 | +4.3% | |
Michael J.M. HitchcockInterim CEO | Open-market buy | 25/12/02 | 25/12/04 | 100,000 sh | $0.99 | $99,000 | +666.7% | |
| Open-market buy | 25/11/28–25/12/01 | 25/12/02 | 50,000 sh2 trades | $1.09avg. | $54,500 | +7.8% | ||
Michael J.M. HitchcockDirector | Open-market buy | 24/09/30 | 24/10/01 | 10,000 sh | $10.06 | $100,600 | +200.0% | |
Franco ValleCFO | Open-market buy | 24/06/11 | 24/06/12 | 12,509 sh | $4.43 | $55,414.87 | +41.7% | |
| Open-market sale | 23/05/31–23/06/01 | 23/06/02 | 125,000 sh2 trades | $34.11avg. | $4,263,750 | −3.4% | ||
A2A Pharmaceuticals10% Owner | Open-market sale | 23/05/12 | 23/05/17 | 25,000 sh | $33.84 | $846,000 | −0.7% | |
| Open-market sale | 23/05/08–23/05/09 | 23/05/10 | 250,000 sh2 trades | $34.30avg. | $8,574,000 | −6.4% | ||
A2A Pharmaceuticals10% Owner | Open-market sale | 23/04/20 | 23/04/26 | 200,000 sh | $29.12 | $5,824,000 | −4.9% | |
| Open-market saleAmendment | 23/03/31 | 23/04/06 | 400,000 sh2 trades | $31.25avg. | $12,500,000 | No record | ||
Cormorant Asset Management10% Owner | Open-market buy | 23/03/30 | 23/04/03 | 400,000 sh | $30.00 | $12,000,000 | +12.6% | |
Bihua ChenDirector | Open-market buy | 23/03/30 | 23/04/03 | 400,000 sh | $30.00 | $12,000,000 | +12.6% | |
| Open-market buy | 23/03/30 | 23/04/03 | 400,000 sh | $30.00 | $12,000,000 | +12.6% | ||
| Open-market buy | 23/03/30 | 23/04/03 | 400,000 sh | $30.00 | $12,000,000 | +12.6% | ||
| Open-market buyAmendment | 21/04/15 | 23/02/10 | 8,400 sh3 trades | $17.00avg. | $142,800 | No record |